Skip to Content
Morningstar

First Trust Long/Short Equity ETF FTLS

Morningstar Medalist Rating
Medalist Rating as of | See First Trust Investment Hub

Morningstar’s Analysis FTLS

Will FTLS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FTLS’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the FTLS management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of FTLS’s parent organization’s priorities and whether they’re in line with investors’ interests.

Increased confidence in First Trust Long/ Short Equity ETF's prospects relative to its Morningstar Category peers results in an upgrade in this strategy's Morningstar Medalist Rating to Neutral from Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FTLS

More FTLS Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 12.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash

29.32 297.1 Mil
Cash and Equivalents

Dreyfus Govt Cm Inst 289

6.25 63.3 Mil
Cash and Equivalents

Microsoft Corp

4.57 46.3 Mil
Technology

NVIDIA Corp

3.79 38.4 Mil
Technology

Apple Inc

3.57 36.2 Mil
Technology

Amazon.com Inc

2.43 24.6 Mil
Consumer Cyclical

Citigroup Inc

2.12 21.5 Mil
Financial Services

Starbucks Corp

1.96 19.8 Mil
Consumer Cyclical

AbbVie Inc

1.89 19.1 Mil
Healthcare

Bristol-Myers Squibb Co

1.85 18.7 Mil
Healthcare